*Nothing in this article should be construed as medical advice. Medical advice should only be sought from a licensed physician. If you are having a medical emergency, please call 9-1-1. If your baby is sick with an illness like NEC, you want the very best medical staff treating them. Finding a doctor you trust or a hospital that fits your needs and will offer the best care available to your infant can be difficult at best. Perhaps you already have an obstetrician or...

HOUSTON, TEXAS – Sullo & Sullo, LLP, a leading law firm based in Houston, Texas, is pleased to announce a $571 Million Dollar* legal victory in the case of "Gration v. Islamic Republic of Iran," a landmark lawsuit arising from the tragic bombing of the Khobar Towers apartment complex in Dhahran, Saudi Arabia, on June 25, 1996.

What is Talcum Powder Ovarian Cancer? Many studies have shown that women who have used talcum powder in the genital region for feminine hygiene purposes may have a much greater risk of being diagnosed with ovarian cancer. It is believed that the microscopic talc fibers travel through a woman’s reproductive system, landing in the ovaries where they embed themselves deep into the ovarian tissues. Once there, the talc fibers cause inflammation—a known cause of many types of cancers. Unfortunately, ovarian cancer is often not diagnosed until it is in later stages, therefore it can be more difficult to treat.

May 04, 2023 - Did Johnson & Johnson Really Just Offer a Settlement for Baby Powder Cases? You may have heard that Johnson & Johnson agreed to pay $8.9 billion dollars to settle tens of thousands of baby powder ovarian cancer lawsuits. While Johnson & Johnson originally offered $2 billion dollars to settle this litigation, this much larger settlement offer may come with particular conditions and restrictions. In fact, the offer in question was only just made in early April, and as of now, it is simply too early to

April 24, 2023 - Of the 22,000 new cases of ovarian cancer diagnosed every year in the U.S., only about 8,000 will live; overall, ovarian cancer has a five-year survival rate of 30 percent. The prognosis for any ovarian cancer diagnosis depends on the “staging” of the cancer. Doctors use a four-part staging method which includes the type of tumor, whether the ovarian cancer has spread to the lymph nodes, whether the cancer has metastasized, and the stage of the cancer.